See also this year's filing and all EDGAR filings for this company.
PDF Report 0001701108_2019_Spero_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001701108, Spero Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 124,219,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,893,000 |
| 3 | remainder_Assets | 1,894,000 |
| 4 | LiabilitiesCurrent | 12,318,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 833,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,887,000 |
| 9 | ResearchAndDevelopmentExpense | 33,885,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 3,966,000 |
| 12 | remainder_NetIncome | 1,144,000 |
| 13 | remainder_ComprehensiveNetIncome | -28,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 129,006,000 |
| 1 | Liabilities | 13,151,000 |
| 2 | Expenses | 46,772,000 |
| 3 | Revenues | 3,966,000 |
| 4 | StockholdersEquity | 115,855,000 |
| 5 | NetIncome | -41,662,000 |
| 6 | ComprehensiveNetIncome | -41,676,000 |
| 7 | BaseVar | 97,033,500 |
| 8 | EconomicCapitalRatio | 2.22 |
Edgar->Model Mapping
Feature Distribution
Change over Time
